Respiratory assessment in centronuclear myopathies

The centronuclear myopathies (CNMs) are a group of inherited neuromuscular disorders classified as congenital myopathies. While several causative genes have been identified, some patients do not harbor any of the currently known mutations. These diverse disorders have common histological features, which include a high proportion of centrally nucleated muscle fibers, and clinical attributes of muscle weakness and respiratory insufficiency. Respiratory problems in CNMs may manifest initially during sleep, but daytime symptoms, ineffective airway clearance, and hypoventilation predominate as more severe respiratory muscle dysfunction evolves. Respiratory muscle capacity can be evaluated using a variety of clinical tests selected with consideration for the age and baseline motor function of the patient. Similar clinical tests of respiratory function can also be incorporated into preclinical CNM canine models to offer insight for clinical trials. Because respiratory problems account for significant morbidity in patients, routine assessments of respiratory muscle function are discussed. Muscle Nerve 50: 315–326, 2014

[1]  L. F. Black,et al.  Maximal static respiratory pressures in generalized neuromuscular disease. , 2015 .

[2]  V. Forin,et al.  Respiratory muscle decline in duchenne muscular dystrophy , 2014, Pediatric pulmonology.

[3]  R. Grange,et al.  Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy , 2014, Science Translational Medicine.

[4]  J. Pépin,et al.  Long-Term Mechanical Ventilation Equipment for Neuromuscular Patients: Meeting the Expectations of Patients and Prescribers , 2014, Respiratory Care.

[5]  V. Forin,et al.  Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3. , 2013, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[6]  Jennifer L. Hefner,et al.  Ventilator-dependent children and the health services system. Unmet needs and coordination of care. , 2013, Annals of the American Thoracic Society.

[7]  Nasim Vasli,et al.  Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy , 2013, Neurology.

[8]  M. Tarnopolsky,et al.  Genotype-phenotype correlations in recessive RYR1-related myopathies , 2013, Orphanet Journal of Rare Diseases.

[9]  E. Malfatti,et al.  An Integrated Diagnosis Strategy for Congenital Myopathies , 2013, PloS one.

[10]  C. Ottenheijm,et al.  P.9.10 Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy , 2013, Neuromuscular Disorders.

[11]  J. Weis,et al.  Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy , 2013, PLoS genetics.

[12]  T. Conlon,et al.  Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes. , 2013, Human gene therapy.

[13]  R. Grange,et al.  Selenoprotein N deficiency in mice is associated with abnormal lung development , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  J. Bach,et al.  Changing Trends in the Management of End-Stage Neuromuscular Respiratory Muscle Failure: Recommendations of an International Consensus , 2013, American journal of physical medicine & rehabilitation.

[15]  E. Bertini,et al.  Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort , 2013, Neuromuscular Disorders.

[16]  G. Nixon,et al.  Paediatric home ventilatory support: Changing milieu, proactive solutions , 2013, Journal of paediatrics and child health.

[17]  R. Matran,et al.  Sniff nasal inspiratory pressure in the longitudinal assessment of young Duchenne muscular dystrophy children , 2012, European Respiratory Journal.

[18]  Daniela Stefanut Ti,et al.  Sniff Nasal Inspiratory Pressure , 2012 .

[19]  R. Grange,et al.  Muscle function in A canine model of X‐linked myotubular myopathy , 2012, Muscle & nerve.

[20]  M. Resende,et al.  Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy , 2012, BMC Research Notes.

[21]  A. Simonds,et al.  British Thoracic Society guideline for respiratory management of children with neuromuscular weakness , 2012, Thorax.

[22]  K. North,et al.  Sniff nasal inspiratory pressure and sleep disordered breathing in childhood neuromuscular disorders , 2012, Neuromuscular Disorders.

[23]  K. Bushby,et al.  Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene‐associated myopathies , 2012, Human mutation.

[24]  B. Fauroux,et al.  Interfaces for long-term noninvasive positive pressure ventilation in children , 2012, Intensive Care Medicine.

[25]  J. Dowling,et al.  Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. , 2012, Human molecular genetics.

[26]  M. Childers,et al.  Establishing clinical end points of respiratory function in large animals for clinical translation. , 2012, Physical medicine and rehabilitation clinics of North America.

[27]  F. Lofaso,et al.  Nocturnal hypoxaemia and hypercapnia in children with neuromuscular disorders , 2011, European Respiratory Journal.

[28]  J. Dowling,et al.  Prevalence of congenital myopathies in a representative pediatric united states population , 2011, Annals of neurology.

[29]  M. Brotto,et al.  Disrupted Membrane Structure and Intracellular Ca2+ Signaling in Adult Skeletal Muscle with Acute Knockdown of Bin1 , 2011, PloS one.

[30]  J. Bach,et al.  Indicators for ventilator use in Duchenne muscular dystrophy. , 2011, Respiratory medicine.

[31]  P. Tissières,et al.  Inspiratory muscle training in a child with nemaline myopathy and organ transplantation , 2010 .

[32]  Sabin R. Bista,et al.  Practice parameters for the respiratory indications for polysomnography in children. , 2011, Sleep.

[33]  V. Kirk,et al.  Executive summary of respiratory indications for polysomnography in children: an evidence-based review. , 2011, Sleep.

[34]  A. Spadari,et al.  Frequency of the Allelic Variant of the PTPLA Gene Responsible for Centronuclear Myopathy in Labrador Retriever Dogs as Assessed in Italy , 2011, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[35]  J. Lainé,et al.  A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice. , 2010, Human molecular genetics.

[36]  Jocelyn Laporte,et al.  Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation , 2010, Orphanet journal of rare diseases.

[37]  B. Tseng,et al.  Consensus Statement on Standard of Care for Congenital Muscular Dystrophies , 2010, Journal of child neurology.

[38]  Straub,et al.  RYR1 mutations are a common cause of congenital myopathies with central nuclei , 2010, Annals of neurology.

[39]  W. Phipatanakul,et al.  Clinically Useful Spirometry in Preschool-Aged Children: Evaluation of the 2007 American Thoracic Society Guidelines , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[40]  B. Banwell,et al.  Nocturnal hypoventilation: predictors and outcomes in childhood progressive neuromuscular disease , 2010, Archives of Disease in Childhood.

[41]  L. Kunkel,et al.  MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers , 2010, Proceedings of the National Academy of Sciences.

[42]  J. Bach,et al.  The respiratory management of patients with duchenne muscular dystrophy: A DMD care considerations working group specialty article , 2010, Pediatric pulmonology.

[43]  N. Romero Centronuclear myopathies: A widening concept , 2010, Neuromuscular Disorders.

[44]  K. Flanigan,et al.  Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy , 2010, Neuromuscular Disorders.

[45]  Chien-Wen Chen,et al.  Involuntary cough strength and extubation outcomes for patients in an ICU. , 2010, Chest.

[46]  H. Panitch Diurnal hypercapnia in patients with neuromuscular disease. , 2010, Paediatric respiratory reviews.

[47]  Julian L Allen Pulmonary complications of neuromuscular disease: a respiratory mechanics perspective. , 2010, Paediatric respiratory reviews.

[48]  T. Conlon,et al.  Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[49]  K. Claeys,et al.  PHENOTYPE OF A PATIENT WITH RECESSIVE CENTRONUCLEAR MYOPATHY AND A NOVEL BIN1 MUTATION , 2010, Neurology.

[50]  F. Muntoni,et al.  Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation , 2010, Neuromuscular Disorders.

[51]  J. Seidman,et al.  Ca2+ dysregulation in Ryr1I4895T/wt mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods , 2009, Proceedings of the National Academy of Sciences.

[52]  L. Boitano Equipment Options for Cough Augmentation, Ventilation, and Noninvasive Interfaces in Neuromuscular Respiratory Management , 2009, Pediatrics.

[53]  M. Sharma,et al.  Congenital myopathies – a comprehensive update of recent advancements , 2009, Acta neurologica Scandinavica.

[54]  J. Benditt,et al.  The American College of Chest Physicians Consensus Statement on the Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy Undergoing Anesthesia or Sedation* , 2009, Pediatrics.

[55]  A. Clément,et al.  Which tests may predict the need for noninvasive ventilation in children with neuromuscular disease? , 2009, Respiratory medicine.

[56]  D. de Benedictis,et al.  Aspiration lung disease. , 2009, Pediatric clinics of North America.

[57]  A. Clément,et al.  Carbon dioxide monitoring during long-term noninvasive respiratory support in children , 2009, Intensive Care Medicine.

[58]  P. Beuret,et al.  Interest of an objective evaluation of cough during weaning from mechanical ventilation , 2009, Intensive Care Medicine.

[59]  A. Greenough,et al.  Measurement of maximal inspiratory pressure in ventilated children , 2008, Pediatric pulmonology.

[60]  Paola Baiardi,et al.  Cough Peak Flows: Standard Values for Children and Adolescents , 2008, American journal of physical medicine & rehabilitation.

[61]  T. Suga,et al.  Mdx respiratory impairment following fibrosis of the diaphragm , 2008, Neuromuscular Disorders.

[62]  N. Romero,et al.  Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset , 2007, Annals of neurology.

[63]  H. Granzier,et al.  Structure–function relations of the giant elastic protein titin in striated and smooth muscle cells , 2007, Muscle & nerve.

[64]  N. Laing Congenital myopathies , 2007, Current opinion in neurology.

[65]  C. Wallgren‐Pettersson,et al.  Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy , 2007, Nature Genetics.

[66]  P. Gay,et al.  Current issues in home mechanical ventilation. , 2007, Chest.

[67]  Ching H. Wang,et al.  Consensus Statement for Standard of Care in Spinal Muscular Atrophy , 2007, Journal of child neurology.

[68]  Janet Stocks,et al.  An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. , 2007, American journal of respiratory and critical care medicine.

[69]  J. Noyes Health and quality of life of ventilator-dependent children. , 2006, Journal of advanced nursing.

[70]  M. Antonelli,et al.  Noninvasive Ventilation in Childhood Acute Neuromuscular Respiratory Failure: A Pilot Study , 2006, Respiration.

[71]  M. Polkey,et al.  Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. , 2006, American journal of respiratory and critical care medicine.

[72]  N. Romero,et al.  Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. , 2006, Brain : a journal of neurology.

[73]  T. Voit,et al.  Predictors of severe chest infections in pediatric neuromuscular disorders , 2006, Neuromuscular Disorders.

[74]  G. Grimby,et al.  Diaphragmatic function in advanced Duchenne muscular dystrophy , 2006, Neuromuscular Disorders.

[75]  David Gozal,et al.  Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. , 2004, American journal of respiratory and critical care medicine.

[76]  T. Voit,et al.  Respiratory function in congenital muscular dystrophy and limb girdle muscular dystrophy 2I , 2004, Neurology.

[77]  A. Simonds,et al.  117th ENMC Workshop: Ventilatory Support in Congenital Neuromuscular Disorders — Congenital Myopathies, Congenital Muscular Dystrophies, Congenital Myotonic Dystrophy and SMA (II) 4–6 April 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.

[78]  M. Polkey,et al.  Limitations of sniff nasal pressure in patients with severe neuromuscular weakness , 2003, Journal of neurology, neurosurgery, and psychiatry.

[79]  Jacob E. Barkley,et al.  Ventilatory dysfunction in mdx mice: Impact of tumor necrosis factor–alpha deletion , 2003, Muscle & nerve.

[80]  G. Kanel,et al.  Tracheobronchomalacia and tracheal hemorrhage in patients with Duchenne muscular dystrophy receiving long-term ventilation with uncuffed tracheostomies. , 2003, Chest.

[81]  A. Simonds,et al.  Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness , 2003, European Respiratory Journal.

[82]  T. Voit,et al.  Daytime predictors of sleep disordered breathing in children and adolescents with neuromuscular disorders , 2003, Neuromuscular Disorders.

[83]  Hala G. Zahreddine,et al.  The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Wayne N Frankel,et al.  The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. , 2002, Genomics.

[85]  E. Hardeman,et al.  A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy. , 2001, Human molecular genetics.

[86]  J. Bach,et al.  Prevention of pulmonary morbidity for patients with neuromuscular disease. , 2000, Chest.

[87]  C. Wallgren‐Pettersson,et al.  MTM1 mutations in X‐linked myotubular myopathy , 2000, Human mutation.

[88]  J. Mandel,et al.  Identification of novel mutations in the MTM1 gene causing severe and mild forms of X‐linked myotubular myopathy , 1999, Human mutation.

[89]  Wei Zhao,et al.  Medical complications in long-term survivors with X-linked myotubular myopathy. , 1999, The Journal of pediatrics.

[90]  M. Polkey,et al.  Influence of acute lung volume change on contractile properties of human diaphragm. , 1998, Journal of applied physiology.

[91]  J. Bach,et al.  Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure. A different approach to weaning. , 1996, Chest.

[92]  A. Barois,et al.  Thoracoabdominal pattern of breathing in neuromuscular disorders. , 1996, Chest.

[93]  J. Marini,et al.  Validation of a technique to assess maximal inspiratory pressure in poorly cooperative patients. , 1992, Chest.

[94]  J. Bach,et al.  LIFE SATISFACTION OF INDIVIDUALS WITH DUCHENNE MUSCULAR DYSTROPHY USING LONG-TERM MECHANICAL VENTILATORY SUPPORT , 1991, American journal of physical medicine & rehabilitation.

[95]  M. Kaufman,et al.  Pulmonary afferent control of breathing as end-expiratory lung volume decreases. , 1990, Journal of applied physiology.

[96]  S. H. Wilson,et al.  Predicted normal values for maximal respiratory pressures in caucasian adults and children. , 1984, Thorax.

[97]  N. Romero,et al.  Centronuclear myopathies. , 2013, Seminars in pediatric neurology.

[98]  C. Wallgren‐Pettersson,et al.  Orphanet Journal of Rare Diseases BioMed Central Review , 2008 .

[99]  A. Clément,et al.  Physiologic benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. , 2008, Chest.

[100]  A. Beggs,et al.  Mutations in dynamin 2 cause dominant centronuclear myopathy. , 2005, Nature genetics.

[101]  C. Wallgren‐Pettersson Congenital myopathies. , 2005, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[102]  D. Annane,et al.  Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. , 2001, Archives of physical medicine and rehabilitation.

[103]  J. Fitting,et al.  Sniff nasal inspiratory pressure. Reference values in Caucasian children. , 1999, American journal of respiratory and critical care medicine.

[104]  Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a consensus conference report. , 1999, Chest.

[105]  C. Gaultier,et al.  Maximal static pressures in healthy children. , 1983, Respiration physiology.

[106]  R. Griggs,et al.  Evaluation of pulmonary function in neuromuscular disease. , 1981, Archives of neurology.